Japanese encephalitis virus perturbs PML-nuclear bodies by engaging in interactions with distinct porcine PML

Songbai Yang1, Huaijin Liu1, Zhenyu Chen1

  • 1Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, College of Animal Science and Technology, College of Veterinary Medicine, Zhejiang A&F University, Hangzhou, China.

Insights

Japanese encephalitis virus (JEV) infection reduces Promyelocytic leukemia protein nuclear bodies (PML-NBs). JEV non-structural proteins interact with PML isoforms, disrupting PML-NBs and potentially weakening the antiviral immune response.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Promyelocytic leukemia (PML) protein and its nuclear bodies (PML-NBs) are crucial for cellular functions and innate immunity against viruses.
  • Viruses often target PML-NBs to evade host immune detection.
  • Japanese encephalitis virus (JEV) causes severe neurological disease, but its immune evasion mechanisms involving PML-NBs are poorly understood.

Purpose of the Study:

  • To investigate how JEV interacts with PML-NBs to evade the host immune response.
  • To identify specific JEV proteins involved in the disruption of PML-NBs.
  • To explore the interaction between JEV proteins and PML isoforms and their effect on viral replication.

Main Methods:

  • Infection of PK15 cells with JEV and enumeration of intracellular PML-NBs.
  • Immunofluorescence assays to visualize PML-NBs and JEV antigen.
  • Cloning and transfection of ten JEV proteins into PK15 cells.
  • Co-transfection of JEV proteins with porcine PML isoforms.
  • Assessment of JEV replication upon ectopic expression of PML isoforms.

Main Results:

  • JEV infection significantly reduced the number of PML-NBs in infected cells.
  • Five JEV non-structural proteins (NS2B, NS3, NS4A, NS4B, NS5) were found to significantly diminish PML-NB quantity.
  • Specific JEV proteins showed distinct colocalization patterns with different PML isoforms (e.g., NS2B with PML4/PML5, NS3/NS5 with all isoforms).
  • PML isoforms PML1, PML3, PML4, and PML5 inhibited JEV replication.

Conclusions:

  • JEV disrupts PML-NB structure by interacting with various PML isoforms.
  • This disruption likely contributes to the evasion of the host's antiviral immune response by JEV.
  • Understanding these interactions provides insights into JEV pathogenesis and potential therapeutic targets.